107 related articles for article (PubMed ID: 22238158)
21. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides.
Hodoniczky J; Sims CG; Best WM; Bentel JM; Wilce JA
Biopolymers; 2008; 90(5):595-603. PubMed ID: 18351583
[TBL] [Abstract][Full Text] [Related]
22. Analysis of hydrophobic and hydrophilic moments of short penetrating peptides for enhancing mitochondrial localization: prediction and validation.
Pirisinu M; Blasco P; Tian X; Sen Y; Bode AM; Liu K; Dong Z
FASEB J; 2019 Jul; 33(7):7970-7984. PubMed ID: 30917009
[TBL] [Abstract][Full Text] [Related]
23. Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells.
Borgne-Sanchez A; Dupont S; Langonné A; Baux L; Lecoeur H; Chauvier D; Lassalle M; Déas O; Brière JJ; Brabant M; Roux P; Péchoux C; Briand JP; Hoebeke J; Deniaud A; Brenner C; Rustin P; Edelman L; Rebouillat D; Jacotot E
Cell Death Differ; 2007 Mar; 14(3):422-35. PubMed ID: 16888644
[TBL] [Abstract][Full Text] [Related]
24. Non-Peptidic Cell-Penetrating Motifs for Mitochondrion-Specific Cargo Delivery.
Appiah Kubi G; Qian Z; Amiar S; Sahni A; Stahelin RV; Pei D
Angew Chem Int Ed Engl; 2018 Dec; 57(52):17183-17188. PubMed ID: 30376611
[TBL] [Abstract][Full Text] [Related]
25. Amphipathic peptide-based fusion peptides and immunoconjugates for the targeted ablation of prostate cancer cells.
Rege K; Patel SJ; Megeed Z; Yarmush ML
Cancer Res; 2007 Jul; 67(13):6368-75. PubMed ID: 17616696
[TBL] [Abstract][Full Text] [Related]
26. Effect of amyloid beta-peptide on permeability transition pore: a comparative study.
Moreira PI; Santos MS; Moreno A; Rego AC; Oliveira C
J Neurosci Res; 2002 Jul; 69(2):257-67. PubMed ID: 12111807
[TBL] [Abstract][Full Text] [Related]
27. A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing.
Ma X; Wang X; Zhou M; Fei H
Adv Healthc Mater; 2013 Dec; 2(12):1638-43. PubMed ID: 23657942
[TBL] [Abstract][Full Text] [Related]
28. Selective apoptotic killing of solid and hematologic tumor cells by bombesin-targeted delivery of mitochondria-disrupting peptides.
Cai H; Yang H; Xiang B; Li S; Liu S; Wan L; Zhang J; Li Y; Cheng J; Lu X
Mol Pharm; 2010 Apr; 7(2):586-96. PubMed ID: 20141196
[TBL] [Abstract][Full Text] [Related]
29. Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction.
Sisemore MF; Zheng J; Yang JC; Thompson DA; Plopper CG; Cortopassi GA; Hammock BD
Arch Biochem Biophys; 2001 Aug; 392(1):32-7. PubMed ID: 11469791
[TBL] [Abstract][Full Text] [Related]
30. The thiol crosslinking agent diamide overcomes the apoptosis-inhibitory effect of Bcl-2 by enforcing mitochondrial permeability transition.
Zamzami N; Marzo I; Susin SA; Brenner C; Larochette N; Marchetti P; Reed J; Kofler R; Kroemer G
Oncogene; 1998 Feb; 16(8):1055-63. PubMed ID: 9519879
[TBL] [Abstract][Full Text] [Related]
31. Apoptosis inducing, conformationally constrained, dimeric peptide analogs of KLA with submicromolar cell penetrating abilities.
Hyun S; Lee S; Kim S; Jang S; Yu J; Lee Y
Biomacromolecules; 2014 Oct; 15(10):3746-52. PubMed ID: 25188534
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, and necrotic cell death.
Huang HM; Ou HC; Xu H; Chen HL; Fowler C; Gibson GE
J Neurosci Res; 2003 Oct; 74(2):309-17. PubMed ID: 14515360
[TBL] [Abstract][Full Text] [Related]
33. Systematic screening of the cellular uptake of designed alpha-helix peptides.
Usui K; Kikuchi T; Mie M; Kobatake E; Mihara H
Bioorg Med Chem; 2013 May; 21(9):2560-7. PubMed ID: 23498920
[TBL] [Abstract][Full Text] [Related]
34. Anti-cancer activity of targeted pro-apoptotic peptides.
Ellerby HM; Arap W; Ellerby LM; Kain R; Andrusiak R; Rio GD; Krajewski S; Lombardo CR; Rao R; Ruoslahti E; Bredesen DE; Pasqualini R
Nat Med; 1999 Sep; 5(9):1032-8. PubMed ID: 10470080
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial targeting functional peptides as potential devices for the mitochondrial delivery of a DF-MITO-Porter.
Kawamura E; Yamada Y; Harashima H
Mitochondrion; 2013 Nov; 13(6):610-4. PubMed ID: 24012978
[TBL] [Abstract][Full Text] [Related]
36. Cellular uptake of an α-AApeptide.
Bai G; Padhee S; Niu Y; Wang RE; Qiao Q; Buzzeo R; Cao C; Cai J
Org Biomol Chem; 2012 Feb; 10(6):1149-53. PubMed ID: 22193209
[TBL] [Abstract][Full Text] [Related]
37. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
Crombez L; Morris MC; Heitz F; Divita G
Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
[TBL] [Abstract][Full Text] [Related]
38. How to clean the dirtiest place in the cell: cationic antioxidants as intramitochondrial ROS scavengers.
Skulachev VP
IUBMB Life; 2005; 57(4-5):305-10. PubMed ID: 16036614
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial glutathione protects against cell death induced by oxidative and nitrative stress in astrocytes.
Muyderman H; Wadey AL; Nilsson M; Sims NR
J Neurochem; 2007 Aug; 102(4):1369-82. PubMed ID: 17484727
[TBL] [Abstract][Full Text] [Related]
40. Patupilone-induced apoptosis is mediated by mitochondrial reactive oxygen species through Bim relocalization to mitochondria.
Khawaja NR; Carré M; Kovacic H; Estève MA; Braguer D
Mol Pharmacol; 2008 Oct; 74(4):1072-83. PubMed ID: 18593821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
